| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 327,835 | 272,160 | 265,238 | 528,233 | | Cost of Revenue | 351,058 | 280,728 | 300,933 | 576,110 | | | Gross Profit | (23,223) | (8,568) | (35,695) | (47,877) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,894 | 63,460 | 49,351 | 71,114 | | Non Recurring |
-
| 9,648 | (9,648) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (49,117) | (81,676) | (75,398) | (118,991) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,502 | 10,809 |
-
| (604) | | Earnings Before Interest And Taxes | (47,448) | (70,853) | (75,349) | (120,870) | | Interest Expense | 4,643 | 2,809 |
-
| (31,722) | | Income Before Tax | (52,091) | (73,662) | (75,349) | (89,148) | | Income Tax Expense | 391 |
-
|
-
| (29,236) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (41,679) | (73,662) | (75,349) | (59,912) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (52,482) | (73,662) | (75,349) | (59,912) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($52,482) | ($73,662) | ($75,349) | ($59,912) |
|
1.52% Nasdaq 0.00%
Income Statement
